Simple blood test could spot multiple cancers early

NCT ID NCT07598747

Recruiting now Diagnosis Sponsor: Chang Gon Kim Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new blood test that looks for DNA from cancer cells. The goal is to see if an artificial intelligence program can accurately detect many different types of cancer at an early stage. The study will include 6,000 adults, some with cancer and some healthy volunteers, to see how well the test works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: blood test (circulating DNA analysis with artificial intelligence)
What this could lead to: If successful, this could lead to a simple blood test that catches many types of cancer early, when they are easier to treat.
What could go wrong: This is an early-stage study focused on developing and validating the test. It is not yet proven to work in the real world, and there is a risk of false positives or false negatives.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer hematopoietic and lymphoid cell neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER HEALTHY PARTICIPANTS

Contacts and locations

Locations

Yonsei Cancer Center
RECRUITING

Seoul, 03722, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.